Ultra‐low‐dose rituximab: Alternative treatment for autoimmune dermatological conditions
Gespeichert in:
| Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2024-07, Vol.38 (7), p.e587-e589 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e589 |
|---|---|
| container_issue | 7 |
| container_start_page | e587 |
| container_title | Journal of the European Academy of Dermatology and Venereology |
| container_volume | 38 |
| creator | Reyes‐Soto, Mayra A. Chavez‐Alvarez, Sonia Yamallel‐Ortega, Luis A. Aguilar‐Calderón, Patrizia E. Perales‐González, Alejandra Villarreal‐Martínez, Alejandra Gómez‐Flores, Minerva Ocampo‐Candiani, Jorge |
| description | |
| doi_str_mv | 10.1111/jdv.19760 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2905524470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2905524470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2850-e09bcf729fc4f37cc49df354ecffa07b582a5b12b48dd765eb4ef2e4a88528de3</originalsourceid><addsrcrecordid>eNp1kDtOxDAQQC0EguVTcAGUEoqA7dgbmw4tfyHRABVS5NhjZOTEYDt8Oo7AGTkJgQU6pphpnp40D6FNgnfJOHv35mmXyHqKF9CEsKkoKyyqRTTBkk5LKblcQasp3WOMCeFiGa1UglSE43qCbq99jurj7d2H53GbkKCILg8vrlPtfnHgM8ReZfcERY6gcgd9LmyIhRpycF039FAYiJ3KwYc7p5UvdOiNyy70aR0tWeUTbPzcNXR9fHQ1Oy0vLk_OZgcXpaaC4xKwbLWtqbSa2arWmkljK85AW6tw3XJBFW8JbZkwpp5yaBlYCkwJwakwUK2h7bn3IYbHAVJuOpc0eK96CENqqMScU8ZqPKI7c1THkFIE2zzE8dX42hDcfMVsxpjNd8yR3frRDm0H5o_8rTcCe3Pg2Xl4_d_UnB_ezJWfuaCC_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2905524470</pqid></control><display><type>article</type><title>Ultra‐low‐dose rituximab: Alternative treatment for autoimmune dermatological conditions</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Reyes‐Soto, Mayra A. ; Chavez‐Alvarez, Sonia ; Yamallel‐Ortega, Luis A. ; Aguilar‐Calderón, Patrizia E. ; Perales‐González, Alejandra ; Villarreal‐Martínez, Alejandra ; Gómez‐Flores, Minerva ; Ocampo‐Candiani, Jorge</creator><creatorcontrib>Reyes‐Soto, Mayra A. ; Chavez‐Alvarez, Sonia ; Yamallel‐Ortega, Luis A. ; Aguilar‐Calderón, Patrizia E. ; Perales‐González, Alejandra ; Villarreal‐Martínez, Alejandra ; Gómez‐Flores, Minerva ; Ocampo‐Candiani, Jorge</creatorcontrib><identifier>ISSN: 0926-9959</identifier><identifier>ISSN: 1468-3083</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.19760</identifier><identifier>PMID: 38131507</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Autoimmune Diseases - drug therapy ; Female ; Humans ; Immunologic Factors - administration & dosage ; Immunologic Factors - therapeutic use ; Male ; Middle Aged ; Rituximab - administration & dosage ; Rituximab - therapeutic use ; Skin Diseases - drug therapy</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2024-07, Vol.38 (7), p.e587-e589</ispartof><rights>2023 European Academy of Dermatology and Venereology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2850-e09bcf729fc4f37cc49df354ecffa07b582a5b12b48dd765eb4ef2e4a88528de3</cites><orcidid>0000-0003-1637-7956 ; 0000-0003-4365-3039 ; 0000-0001-9433-5976 ; 0000-0002-0213-0031 ; 0000-0002-4783-3793 ; 0000-0003-3307-5503</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.19760$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.19760$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38131507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reyes‐Soto, Mayra A.</creatorcontrib><creatorcontrib>Chavez‐Alvarez, Sonia</creatorcontrib><creatorcontrib>Yamallel‐Ortega, Luis A.</creatorcontrib><creatorcontrib>Aguilar‐Calderón, Patrizia E.</creatorcontrib><creatorcontrib>Perales‐González, Alejandra</creatorcontrib><creatorcontrib>Villarreal‐Martínez, Alejandra</creatorcontrib><creatorcontrib>Gómez‐Flores, Minerva</creatorcontrib><creatorcontrib>Ocampo‐Candiani, Jorge</creatorcontrib><title>Ultra‐low‐dose rituximab: Alternative treatment for autoimmune dermatological conditions</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><subject>Adult</subject><subject>Autoimmune Diseases - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Immunologic Factors - administration & dosage</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Rituximab - administration & dosage</subject><subject>Rituximab - therapeutic use</subject><subject>Skin Diseases - drug therapy</subject><issn>0926-9959</issn><issn>1468-3083</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kDtOxDAQQC0EguVTcAGUEoqA7dgbmw4tfyHRABVS5NhjZOTEYDt8Oo7AGTkJgQU6pphpnp40D6FNgnfJOHv35mmXyHqKF9CEsKkoKyyqRTTBkk5LKblcQasp3WOMCeFiGa1UglSE43qCbq99jurj7d2H53GbkKCILg8vrlPtfnHgM8ReZfcERY6gcgd9LmyIhRpycF039FAYiJ3KwYc7p5UvdOiNyy70aR0tWeUTbPzcNXR9fHQ1Oy0vLk_OZgcXpaaC4xKwbLWtqbSa2arWmkljK85AW6tw3XJBFW8JbZkwpp5yaBlYCkwJwakwUK2h7bn3IYbHAVJuOpc0eK96CENqqMScU8ZqPKI7c1THkFIE2zzE8dX42hDcfMVsxpjNd8yR3frRDm0H5o_8rTcCe3Pg2Xl4_d_UnB_ezJWfuaCC_w</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Reyes‐Soto, Mayra A.</creator><creator>Chavez‐Alvarez, Sonia</creator><creator>Yamallel‐Ortega, Luis A.</creator><creator>Aguilar‐Calderón, Patrizia E.</creator><creator>Perales‐González, Alejandra</creator><creator>Villarreal‐Martínez, Alejandra</creator><creator>Gómez‐Flores, Minerva</creator><creator>Ocampo‐Candiani, Jorge</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1637-7956</orcidid><orcidid>https://orcid.org/0000-0003-4365-3039</orcidid><orcidid>https://orcid.org/0000-0001-9433-5976</orcidid><orcidid>https://orcid.org/0000-0002-0213-0031</orcidid><orcidid>https://orcid.org/0000-0002-4783-3793</orcidid><orcidid>https://orcid.org/0000-0003-3307-5503</orcidid></search><sort><creationdate>202407</creationdate><title>Ultra‐low‐dose rituximab: Alternative treatment for autoimmune dermatological conditions</title><author>Reyes‐Soto, Mayra A. ; Chavez‐Alvarez, Sonia ; Yamallel‐Ortega, Luis A. ; Aguilar‐Calderón, Patrizia E. ; Perales‐González, Alejandra ; Villarreal‐Martínez, Alejandra ; Gómez‐Flores, Minerva ; Ocampo‐Candiani, Jorge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2850-e09bcf729fc4f37cc49df354ecffa07b582a5b12b48dd765eb4ef2e4a88528de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Autoimmune Diseases - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Immunologic Factors - administration & dosage</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Rituximab - administration & dosage</topic><topic>Rituximab - therapeutic use</topic><topic>Skin Diseases - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reyes‐Soto, Mayra A.</creatorcontrib><creatorcontrib>Chavez‐Alvarez, Sonia</creatorcontrib><creatorcontrib>Yamallel‐Ortega, Luis A.</creatorcontrib><creatorcontrib>Aguilar‐Calderón, Patrizia E.</creatorcontrib><creatorcontrib>Perales‐González, Alejandra</creatorcontrib><creatorcontrib>Villarreal‐Martínez, Alejandra</creatorcontrib><creatorcontrib>Gómez‐Flores, Minerva</creatorcontrib><creatorcontrib>Ocampo‐Candiani, Jorge</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reyes‐Soto, Mayra A.</au><au>Chavez‐Alvarez, Sonia</au><au>Yamallel‐Ortega, Luis A.</au><au>Aguilar‐Calderón, Patrizia E.</au><au>Perales‐González, Alejandra</au><au>Villarreal‐Martínez, Alejandra</au><au>Gómez‐Flores, Minerva</au><au>Ocampo‐Candiani, Jorge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ultra‐low‐dose rituximab: Alternative treatment for autoimmune dermatological conditions</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2024-07</date><risdate>2024</risdate><volume>38</volume><issue>7</issue><spage>e587</spage><epage>e589</epage><pages>e587-e589</pages><issn>0926-9959</issn><issn>1468-3083</issn><eissn>1468-3083</eissn><cop>England</cop><pmid>38131507</pmid><doi>10.1111/jdv.19760</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-1637-7956</orcidid><orcidid>https://orcid.org/0000-0003-4365-3039</orcidid><orcidid>https://orcid.org/0000-0001-9433-5976</orcidid><orcidid>https://orcid.org/0000-0002-0213-0031</orcidid><orcidid>https://orcid.org/0000-0002-4783-3793</orcidid><orcidid>https://orcid.org/0000-0003-3307-5503</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0926-9959 |
| ispartof | Journal of the European Academy of Dermatology and Venereology, 2024-07, Vol.38 (7), p.e587-e589 |
| issn | 0926-9959 1468-3083 1468-3083 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2905524470 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Adult Autoimmune Diseases - drug therapy Female Humans Immunologic Factors - administration & dosage Immunologic Factors - therapeutic use Male Middle Aged Rituximab - administration & dosage Rituximab - therapeutic use Skin Diseases - drug therapy |
| title | Ultra‐low‐dose rituximab: Alternative treatment for autoimmune dermatological conditions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A05%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ultra%E2%80%90low%E2%80%90dose%20rituximab:%20Alternative%20treatment%20for%20autoimmune%20dermatological%20conditions&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Reyes%E2%80%90Soto,%20Mayra%20A.&rft.date=2024-07&rft.volume=38&rft.issue=7&rft.spage=e587&rft.epage=e589&rft.pages=e587-e589&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.19760&rft_dat=%3Cproquest_cross%3E2905524470%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2905524470&rft_id=info:pmid/38131507&rfr_iscdi=true |